Literature DB >> 10082529

Synergism with germ line transcription factor Oct-4: viral oncoproteins share the ability to mimic a stem cell-specific activity.

A Brehm1, K Ohbo, W Zwerschke, V Botquin, P Jansen-Dürr, H R Schöler.   

Abstract

Activation of transcription by Oct-4 from remote binding sites requires a cofactor that is restricted to embryonal stem cells. The adenovirus E1A protein can mimic the activity of this stem cell-specific factor and stimulates Oct-4 activity in differentiated cells. Here we characterize the Oct-4-E1A interaction and show that the E1A 289R protein harbors two independent Oct-4 binding sites, both of which specifically interact with the POU domain of Oct-4. Furthermore, we demonstrate that, like E1A, the human papillomavirus E7 oncoprotein also specifically binds to the Oct-4 POU domain. E7 and Oct-4 can form a complex both in vitro and in vivo. Expression of E7 in differentiated cells stimulates Oct-4-mediated transactivation from distal binding sites. Moreover, Oct-4, but not other Oct factors, is active when expressed in cells transformed by human papillomavirus. Our results suggest that different viruses have evolved oncoproteins that share the ability to target Oct-4 and to mimic a stem cell-specific activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082529      PMCID: PMC84056          DOI: 10.1128/MCB.19.4.2635

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  A nexus between Oct-4 and E1A: implications for gene regulation in embryonic stem cells.

Authors:  H R Schöler; T Ciesiolka; P Gruss
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

2.  Identification of distinct roles for separate E1A domains in disruption of E2F complexes.

Authors:  M A Ikeda; J R Nevins
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

3.  Regulation of the Oct-4 gene by nuclear receptors.

Authors:  I Sylvester; H R Schöler
Journal:  Nucleic Acids Res       Date:  1994-03-25       Impact factor: 16.971

4.  A family of transcriptional adaptor proteins targeted by the E1A oncoprotein.

Authors:  Z Arany; D Newsome; E Oldread; D M Livingston; R Eckner
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

Review 5.  Octamania: the POU factors in murine development.

Authors:  H R Schöler
Journal:  Trends Genet       Date:  1991-10       Impact factor: 11.639

6.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

7.  Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators.

Authors:  C M Chiang; R G Roeder
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

8.  Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells.

Authors:  A Mal; R Y Poon; P H Howe; H Toyoshima; T Hunter; M L Harter
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

9.  Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells.

Authors:  R S Slack; P A Hamel; T S Bladon; R M Gill; M W McBurney
Journal:  Oncogene       Date:  1993-06       Impact factor: 9.867

10.  Oct-4: a germline-specific transcription factor mapping to the mouse t-complex.

Authors:  H R Schöler; G R Dressler; R Balling; H Rohdewohld; P Gruss
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

View more
  13 in total

1.  Repression of Ets-2-induced transactivation of the tau interferon promoter by Oct-4.

Authors:  T Ezashi; D Ghosh; R M Roberts
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

2.  Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells.

Authors:  Hitoshi Niwa; Shinji Masui; Ian Chambers; Austin G Smith; Jun-ichi Miyazaki
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus.

Authors:  Masazumi Nishimoto; Satoru Miyagi; Toshiyuki Yamagishi; Takehisa Sakaguchi; Hitoshi Niwa; Masami Muramatsu; Akihiko Okuda
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells.

Authors:  Zhenguang Chen; Tao Wang; Lie Cai; Chunhua Su; Beilong Zhong; Yiyan Lei; Andy Peng Xiang
Journal:  J Exp Clin Cancer Res       Date:  2012-02-02

5.  Molecular basis of Mammalian embryonic stem cell pluripotency and self-renewal.

Authors:  S P Medvedev; A I Shevchenko; S M Zakian
Journal:  Acta Naturae       Date:  2010-07       Impact factor: 1.845

6.  Use of altered-specificity binding Oct-4 suggests an absence of pluripotent cell-specific cofactor usage.

Authors:  Alexander E F Smith; Kevin G Ford
Journal:  Nucleic Acids Res       Date:  2005-10-20       Impact factor: 16.971

Review 7.  Changing Stem Cell Dynamics during Papillomavirus Infection: Potential Roles for Cellular Plasticity in the Viral Lifecycle and Disease.

Authors:  Katerina Strati
Journal:  Viruses       Date:  2017-08-12       Impact factor: 5.048

8.  Oct-4 controls cell-cycle progression of embryonic stem cells.

Authors:  Jungwoon Lee; Yeorim Go; Inyoung Kang; Yong-Mahn Han; Jungho Kim
Journal:  Biochem J       Date:  2010-02-09       Impact factor: 3.857

9.  HPV-Induced Field Cancerisation: Transformation of Adult Tissue Stem Cell Into Cancer Stem Cell.

Authors:  Carlotta Olivero; Simone Lanfredini; Cinzia Borgogna; Marisa Gariglio; Girish K Patel
Journal:  Front Microbiol       Date:  2018-03-26       Impact factor: 5.640

10.  Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer.

Authors:  Ken-Ichi Takayama; Takeo Kosaka; Takashi Suzuki; Hiroshi Hongo; Mototsugu Oya; Tetsuya Fujimura; Yutaka Suzuki; Satoshi Inoue
Journal:  Nat Commun       Date:  2021-06-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.